Skip to main content
SpringerLink
Log in

Inactivation of Animal Factor VIII by human Factor VIII Inhibitors: Investigation of Plasma from Patients with Inhibitors in congenital Hemophilia A and from Patients with acquired Hemophilia A

  • Conference paper
32nd Hemophilia Symposium

  • 109 Accesses

Abstract

In a number of patients with congenital Hemophilia A the treatment is complicated by the presence of factor VIII inhibitors. These are alloantibodies which the patients only develop after receiving replacement therapy with factor VIII preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gilles JGG, Jacquemin MG, Saint Remy JMR. Factor VIII inhibitors. Thromb Haemost 1997; 78: 641–646

    PubMed  CAS  Google Scholar 

  2. Green D. Acquired factor VIII inhibitors and immunosuppression of autoantibodies. In: Kessler C, Garvey MB, Green D, Kasper C, Lusher J (eds). Acquired hemophilia. Excerpta Medica Princetown 1995; 25–40

    Google Scholar 

  3. Green D, Blanc J, Foiles N. Spontaneous inhibitors of factor VIII: kinetics of inactivation of human and porcine factor VIII. J Lab Clin Med 1999; 133: 260–264

    Article  PubMed  CAS  Google Scholar 

  4. Hay CR. Porcine factor VIII: past, present and future. Haematologica 2000; 85(10 Suppl): 21–24

    PubMed  CAS  Google Scholar 

  5. Hay CRM, Baglin TP, Collins PW, Hill FGH, Keeling DM. The diagnosis and Management of factor VIII and IX inhibitors: A guideline from the UK Haemophilia Centre Doctor’s Organization (UKHCDO). Brit J Haematol 2000; 111: 78–90

    Article  CAS  Google Scholar 

  6. Hoyer LW. Inhibitors in hemophilia. In: Forbes CD, Aledort L, Madhok R (eds). Hemophilia. Chapman Hall London 1997; 213–227

    Google Scholar 

  7. Huhmann I, Lechner K. Spontane Faktor Vlll-Inhibitoren. Hämostaseologie 1996; 16: 164–170

    CAS  Google Scholar 

  8. Kasper CK. Laboratory diagnosis of factor VIII inhibitors. In: Kessler C, Garvey MB, Green D, Kasper C, Lusher J (eds). Acquired hemophilia. Excerpta Medica Princetown 1995; 9–23

    Google Scholar 

  9. Kessler CM. The treatment of acquired factor VIII inhibitors: Worldwide experience with porcine factor VIII. In: Kessler C, Garvey MB, Green D, Kasper C, Lusher J (eds). Acquired hemophilia. Excerpta Medica Princetown 1995; 71–89

    Google Scholar 

  10. Lechner K. Antikörperbildung — die derzeit gravierendste Komplikation der Substitutionstherapie bei Hämophilie. In: Scharrer I, Schramm W (eds). 26. Hämophilie-Symposion Hamburg 1995. Springer Berlin Heidelberg 1997; 61–67

    Google Scholar 

  11. Lutze G, Kutschmann K, Thomae K, Lutze GJR, Franke D. Erfolgreicher therapeutischer Einsatz von porcinem Faktor VIII bei der Hämophilie A des Hundes. Prakt Tierarzt 1999; 80: 664–670

    Google Scholar 

  12. Lutze GJR. Untersuchungen zur Wirkung von Gerinnungsfaktor Vlll-Inhibitoren bei angeborenem und erworbenem Faktor VIII-Mangel (Hemmkörperhämophilie A und spontane Hämophilie A) auf tierischen Faktor VIII. Otto-von-Guericke-Universität Magdeburg 2000; Inauguraldissertation

    Google Scholar 

  13. Meili EO, Von Feiten A. Bestimmt die Art der Blutstillung den klinischen Verlauf bei Patienten Mit erworbener Hemmkörperhämophilie? In: Scharrer I, Schramm W (eds). 27. Hämophilie-Symposion Hamburg 1996. Springer Berlin Heidelberg 1998; 89–91

    Google Scholar 

  14. Moliterno A, Bell WR. Acquired coagulation inhibitors in the non-congenital factor deficient population: Clinical Manifestations and Management. In: Scharrer I, Schramm W (eds). 27. Hämophilie-Symposion Hamburg 1996. Springer Berlin Heidelberg 1998; 67–75

    Chapter  Google Scholar 

  15. Scharrer I. Acquired inhibitors against factor VIII and factor IX. In: Hach-Wunderle V, Nawroth PP (eds). Life-threatening coagulation disorders in critical care Medicine. Springer Berlin Heidelberg 1997; 51–59

    Chapter  Google Scholar 

  16. Shapiro SS, Rajagopalan V. Hemorrhagic disorders associated with circulating inhibitors. In: Ratnoff OD, Forbes CD (eds). Disorders of hemostasis. W.B. Saunders Philadelphia London 1996; 208–227

    Google Scholar 

  17. Tuddenham EGD, McVey JH. The genetic basis of inhibitor development in haemophilia A. Haemophilia 1998; 4: 543–545

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. V. Aumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Lutze Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Lutze Sr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Franke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U. Mittler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hemophilia Center, Dept. of Internal Medicine, University Hospital, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Germany

    Inge Scharrer

  2. Dept. of Hemostasiology, University Hospital, Ziemssenstr. 1a, D-80336, München, Germany

    Wolfgang Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Aumann, V., Lutze, G., Lutze, G., Franke, D., Mittler, U. (2003). Inactivation of Animal Factor VIII by human Factor VIII Inhibitors: Investigation of Plasma from Patients with Inhibitors in congenital Hemophilia A and from Patients with acquired Hemophilia A. In: Scharrer, I., Schramm, W. (eds) 32nd Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18150-4_43

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18150-4_43

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-43884-7

  • Online ISBN: 978-3-642-18150-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation